Synthesis and extracellular accumulation of silver nanoparticles by employing radiation-resistant Deinococcus radiodurans, their characterization, and determination of bioactivity

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 963-974

  Kulkarni, Rasika R ^a   Shaiwale, Nayana S ^a   Deobagkar, Dileep N ^a   Deobagkar, Deepti D ^a  

^a UNIVERSITY OF PUNE   (India)

Author keywords

Anti biofouling; Antibacterial; Anticancer; Deinococcus radiodurans; Radiation resistance; Silver nanoparticles

Indexed keywords

ANTIBIOTIC AGENT; SILVER NANOPARTICLE; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; METAL NANOPARTICLE; SILVER;

ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL STRAIN; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; DEINOCOCCUS RADIODURANS; DESICCATION; ECOLOGICAL NICHE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GROWTH INHIBITION; INFRARED SPECTROSCOPY; MICROBIAL ACTIVITY; NONHUMAN; PH; PROCESS OPTIMIZATION; RADIATION RESISTANT DEINOCOCCUS RADIODURANS; RADIOSENSITIVITY; ROENTGEN SPECTROSCOPY; SCANNING ELECTRON MICROSCOPY; SPECIES DIVERSITY; SPECIES RICHNESS; TEMPERATURE; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROSCOPY; X RAY DIFFRACTION; BACTERIUM; CHEMISTRY; DEINOCOCCUS; DRUG EFFECTS; HUMAN; MCF-7 CELL LINE;

DEINOCOCCUS RADIODURANS; NEGIBACTERIA; POSIBACTERIA;

ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; BACTERIA; CELL PROLIFERATION; DEINOCOCCUS; HUMANS; HYDROGEN-ION CONCENTRATION; MCF-7 CELLS; METAL NANOPARTICLES; SILVER; TEMPERATURE;

EID: 84922119103     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S72888     Document Type: Article

References (47)

1. Jain J, Arora S, Rajwade JM, Omray P, Khandelwal S, Paknikar KM. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use. Mol Pharm. 2009;6:1388–1401.
2. Kalele SA, Kundu AA, Gosavi SW, Deobagkar DN, Deobagkar DD, Kulkarni SK. Rapid detection of Escherichia coli by using antibody conjugated silver nanoshells. Small. 2006;2:335–338.
3. Kalele SA, Ashtaputre SS, Hebalkar NY, et al. Optical detection of antibody using silica “silver core” shell particles. Chem Phys Lett. 2005;404:136–141.
4. Prabhu S, Poulose EK. Silver nanoparticles: mechanism of antimicrobial action, synthesis, medical applications, and toxicity effects. Int Nano Lett. 2012;2:1–10.
5. Morley KS, Webb PB, Tokareva NV, et al. Synthesis and characterization of advanced UHMWPE/silver nanocomposites for biomedical applications. Eur Polym J. 2007;43:307–314.
6. Pariser RJ. Generalized argyria. Clinicopathologic features and his-tochemical studies. Arch Dermatol. 1978;114:373–377.
7. Panyala NR, Pena-Mendez EM, Havel J. Silver or silver nanoparticles: a hazardous threat to the environment and human health? J Appl Biomed. 2008;6:117–129.
8. Thakkar KN, Mhatre SS, Parikh RY. Biological synthesis of metallic nanoparticles. Nanomedicine. 2012;6:257–262.
9. Xie J, Lee JY, Wang DIC, Ting YP. Silver nanoplates: from biological to biomimetic synthesis. ACS Nano. 2007;1:429–439.
10. Gericke M, Pinches A. Biological synthesis of metal nanoparticles. Hydrometallurgy. 2006;83:132–140.
11. Shivaji S, Madhu S, Singh S. Extracellular synthesis of antibacterial silver nanoparticles using psychrophilic bacteria. Process Biochem. 2011;46:1800–1807.
12. Kim Y, Lee BG, Roh Y. Microbial synthesis of silver nanoparticles. J Nanosci Nanotechnol. 2013;13:3897–3900.
13. Nies DH. Microbial heavy-metal resistance. Appl Microbiol Biotechnol. 1999;51:730–750.
14. Lemire JA, Harrison JJ, Turner RJ. Antimicrobial activity of metals: mechanisms, molecular targets and applications. Nat Rev Microbiol. 2013;11:371–384.
15. Yates MD, Cusick RD, Logan BE. Extracellular palladium nanoparticle production using Geobacter sulfurreducens. ACS Sustain Chem Eng. 2013;1:1165–1171.
16. Konishi Y, Tsukiyama T, Tachimi T, Saitoh N, Nomura T, Nagamine S. Microbial deposition of gold nanoparticles by the metal-reducing bacterium Shewanella algae. Electrochim Acta. 2007;53:186–192.
17. Moon JW, Roh Y, Lauf RJ, Vali H, Yeary LW, Phelps TJ. Microbial preparation of metal-substituted magnetite nanoparticles. J Microbiol Methods. 2007;70:150–158.
18. Fredrickson JK, Kostandarithes HM, Li SW, Plymale AE, Daly MJ. Reduction of Fe (III), Cr (VI), U (VI), and Tc (VII) by Deinococcus radiodurans R1. Appl Environ Microbiol. 2000;66:2006–2011.
19. Brim H, McFarlan SC, Fredrickson JK, et al. Engineering Deinococcus radiodurans for metal remediation in radioactive mixed waste environments. Nat Biotechnol. 2000;18:85–90.
20. Brim H, Osborne JP, Kostandarithes HM, Fredrickson JK, Wackett LP, Daly MJ. Deinococcus radiodurans engineered for complete toluene degradation facilitates Cr (VI) reduction. Microbiology. 2006; 152:2469–2477.
21. Appukuttan D, Rao AS, Apte SK. Engineering of Deinococcus radio-durans R1 for bioprecipitation of uranium from dilute nuclear waste. Appl Environ Microbiol. 2006;72:7873–7878.
22. Mark SS, Bergkvist M, Yang X, et al. Bionanofabrication of metallic and semiconductor nanoparticle arrays using S-layer protein lattices with different lateral spacings and geometries. Langmuir. 2006;22:3763–3774.
23. Nathan P, Law EJ, Murphy DF, MacMillan BG. A laboratory method for selection of topical antimicrobial agents to treat infected burn wounds. Burns. 1978;4:177–187.
24. Stepanović S, Vuković D, Hola V, et al. Quantification of bioflm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS. 2007;115:891–899.
25. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 1987;47:936–942.
26. Wiley BJ, Im SH, Li ZY, McLellan J, Siekkinen A, Xia Y. Maneuvering the surface plasmon resonance of silver nanostructures through shape-controlled synthesis. J Phys Chem B. 2006;110:15666–15675.
27. Huang H, Yang X. Synthesis of polysaccharide-stabilized gold and silver nanoparticles: a green method. Carbohydr Res. 2004;339: 2627–2631.
28. Gurunathan S, Kalishwaralal K, Vaidyanathan R, et al. Biosynthesis, purifcation and characterization of silver nanoparticles using Escheri-chia coli. Colloids Surf B Biointerfaces. 2009;74:328–335.
29. Murphy CJ, Gole AM, Hunyadi SE, Orendorff CJ. One-dimensional colloidal gold and silver nanostructures. Inorg Chem. 2006;45:7544–7554.
30. Chen J, Wiley BJ, Xia Y. One-dimensional nanostructures of metals: large-scale synthesis and some potential applications. Langmuir. 2007; 23:4120–4129.
31. Binupriya AR, Sathishkumar M, Yun SI. Myco-crystallization of silver ions to nanosized particles by live and dead cell fltrates of Aspergillus oryzae var. viridis and its bactericidal activity toward Staphylococcus aureus KCCM 12256. Ind Eng Chem Res. 2009;49:852–858.
32. Klaus T, Joerger R, Olsson E, Granqvist CG. Silver-based crystalline nanoparticles, microbially fabricated. Proc Natl Acad Sci U S A. 1999; 96:13611–13614.
33. Saravanan M, Vemu AK, Barik SK. Rapid biosynthesis of silver nano-particles from Bacillus megaterium (NCIM 2326) and their antibacterial activity on multi drug resistant clinical pathogens. Colloids Surf B Biointerfaces. 2011;88:325–331.
34. Shahverdi AR, Minaeian S, Shahverdi HR, Jamalifar H, Nohi AA. Rapid synthesis of silver nanoparticles using culture supernatants of Enterobacte-ria: a novel biological approach. Process Biochem. 2007;42:919–923.
35. Kalimuthu K, Suresh Babu R, Venkataraman D, Bilal M, Gurunathan S. Biosynthesis of silver nanocrystals by Bacillus licheniformis. Colloids Surf B Biointerfaces. 2008;65:150–153.
36. Sastry M, Ahmad A, Islam Khan nanoparticles using fungi and actinomycete. Curr Sci. 2003;85: 162–170.
37. Sathishkumar M, Sneha K, Yun YS. Immobilization of silver nanoparticles synthesized using Curcuma longa tuber powder and extract on cotton cloth for bactericidal activity. Bioresour Technol. 2010;101:7958–7965.
38. Dhanalakshmi M. Silver nanoparticles and its antibacterial activity. Int J Pharm Biol Arch. 2013;4:819–826.
39. Rai MK, Deshmukh SD, Ingle AP, Gade AK. Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria. J Appl Microbiol. 2012;112:841–852.
40. Bankura KP, Maity D, Mollick MM, et al. Synthesis, characterization and antimicrobial activity of dextran stabilized silver nanoparticles in aqueous medium. Carbohydr Polym. 2012;89:1159–1165.
41. Ruparelia JP, Chatterjee AK, Duttagupta SP, Mukherji S. Strain speci-fcity in antimicrobial activity of silver and copper nanoparticles. Acta Biomater. 2008;4:707–716.
42. Kim JS, Kuk E, Yu KN, et al. Antimicrobial effects of silver nanopar-ticles. Nanomedicine. 2007;3:95–101.
43. Guzman M, Dille J, Godet SP. Synthesis and antibacterial activity of silver nanoparticles against Gram-positive and Gram-negative bacteria. Nanomedicine. 2012;8:37–45.
44. Radzig MA, Nadtochenko VA, Koksharova OA, Kiwi J, Lipasova VA, Khmel IA. Antibacterial effects of silver nanoparticles on Gram-negative bacteria: influence on the growth and bioflms formation, mechanisms of action. Colloids Surf B Biointerfaces. 2013;102: 300–306.
45. Raghunandan D, Ravishankar B, Sharanbasava G, et al. Anti-cancer studies of noble metal nanoparticles synthesized using different plant extracts. Cancer Nanotechnol. 2011;2:57–65.
46. Lima R, Seabra AB, Duran N. Silver nanoparticles: a brief review of cytotoxicity and genotoxicity of chemically and biogenically synthesized nanoparticles. J Appl Toxicol. 2012;32:867–879.
47. Liu W, Wu Y, Wang C, et al. Impact of silver nanoparticles on human cells: effect of particle size. Nanotoxicology. 2010;4:319–330.